Inform Genomics Appoints Carl de Moor
News Jul 30, 2014
Inform Genomics, Inc has announced the appointment of Carl de Moor, PhD, as Chief Technology Officer.
"We are very pleased to have Carl join Inform Genomics as a member of our senior management and executive team. Carl's vast industry and academic expertise in the biostatistics and health outcomes space will significantly aid Inform Genomics as we continue to grow the Company," said Ed Rubenstein, MD, President and CEO of Inform Genomics.
Dr de Moor has more than 25 years of experience in epidemiology, biostatistics, and health outcomes research. His areas of expertise include pharmacoepidemiologic study designs, patient-reported outcome (PRO) assessment methodology and analysis, predictive modeling, longitudinal and time varying modeling, correlated data methods, and multivariate methods.
Prior to joining Inform Genomics, Dr de Moor was Senior Principal Epidemiology and Lead, Epidemiology Center of Excellence, at IMS Health, where he designed and directed retrospective epidemiologic research.
He has served in several executive roles in industry, including Vice President of Epidemiology at MAPI, a late-phase CRO; Executive Director Epidemiology and Health Outcomes at PPD, Inc.; and Vice President of Health Outcomes and Pharmacoeconomics at Supportive Oncology Services, Inc, an oncology CRO.
Identical Twin Study Shows Impact of a Lifetime of Exercise on FItnessNews
When it comes to being fit, are genes or lifestyle more important? Researchers removed the nature part of the equation by studying a pair of identical twins who had taken radically different fitness paths over three decades. One became an Ironman triathlete while the other remained relatively sedentary over the last 30 years.
Analytical Tool Predicts Disease-Causing GenesNews
Predicting genes that can cause disease due to the production of truncated or altered proteins that take on a new or different function, rather than those that lose their function, is now possible thanks to an international team of researchers that has developed a new analytical tool to effectively and efficiently predict such candidate genes.